![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neur... Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.25 | -14.6198830409 | 8.55 | 8.66 | 6.915 | 712052 | 7.53718415 | CS |
4 | 0.03 | 0.41265474553 | 7.27 | 8.7451 | 6.915 | 738274 | 7.80461 | CS |
12 | -1.85 | -20.218579235 | 9.15 | 10.52 | 6.56 | 1286294 | 8.1212344 | CS |
26 | -5.03 | -40.7948094079 | 12.33 | 13.48 | 6.56 | 898897 | 9.07654507 | CS |
52 | -9.1 | -55.487804878 | 16.4 | 28.8 | 6.56 | 755343 | 12.19338236 | CS |
156 | -18.03 | -71.1804184761 | 25.33 | 35.73 | 6.56 | 531008 | 17.11663774 | CS |
260 | -46.96 | -86.5462587541 | 54.26 | 54.63 | 6.56 | 481048 | 23.54042116 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions